Download presentation
Presentation is loading. Please wait.
Published byVerity Hodge Modified over 6 years ago
1
Adding Evidence to Frontline Hormone Receptor-Positive Breast Cancer Treatments
2
Introduction Advanced Hormone Receptor-Positive Breast Cancer
3
First-Line Endocrine Therapy in Advanced Breast Cancer Choice of ET ± CDK 4/6 Inhibitor
4
Visceral Crisis
5
FALCON Anastrozole vs Fulvestrant in Hormone Receptor-Positive Advanced Breast Cancer
6
FALCON Trial Results
8
Fulvestrant in ER-Positive Advanced Breast Cancer CONFIRM Phase 3, Double-Blind Trial
9
Comparison of Recent First-Line Studies for ER-Positive Advanced Breast Cancer
10
Overcoming Endocrine Resistance in Metastatic Breast Cancer
11
PALOMA-2 Palbociclib + Letrozole vs Letrozole Alone
12
MONALEESA-2 Ribociclib + Letrozole vs Letrozole in Hormone Receptor-Positive Advanced Breast Cancer
13
Palbociclib Management of Hematological Toxicities
14
How Do We Determine First-Line Therapy?
15
BOLERO-2 Everolimus + Exemestane vs Placebo + Exemestane
16
SWISH Trial Dexamethasone-Based Mouthwash for Stomatitis
17
Concluding Remarks
18
Abbreviations
19
Abbreviations (cont)
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.